Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Rocket Doctor AI ( (TSE:AIDR) ).
Rocket Doctor AI has signed an agreement with a major New York insurer that brings its AI-enabled digital health platform in-network for 2.4 million additional members across the state. The deal spans Medicaid Managed Care, HARP, Medicare Advantage, dual-eligible plans, Managed Long-Term Care and individual coverage, widening access to board-certified physicians for medical and behavioral health services.
The contract deepens the company’s presence in one of the largest U.S. healthcare markets and embeds its physician-led platform more firmly within established payer networks. Combined with earlier New York contracts, Rocket Doctor’s in-network reach now exceeds 15 million covered lives, underscoring rapid payer network expansion and strengthening its position as a technology-enabled care provider for high-need and government-sponsored populations.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.70 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. is a digital health company that delivers physician-built, AI-powered solutions aimed at improving access to high-quality care across the patient journey. Its core Global Library of Medicine decision-support system and the Rocket Doctor Inc. telehealth marketplace enable more than 300 physicians to run virtual or hybrid practices, supporting over 700,000 patient visits, with a particular focus on underserved, rural and remote communities in Canada and key U.S. markets.
Average Trading Volume: 227,693
Technical Sentiment Signal: Sell
Current Market Cap: C$51.83M
For an in-depth examination of AIDR stock, go to TipRanks’ Overview page.